NCT01662778View on ClinicalTrials.gov

The Clinical Effect of Monodisperse Fluticasone Propionate in Asthma

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Asthma
Interventions
DRUG

1.5 microns at 50mg

STAG generated monodisperse 1.5micron particles

DRUG

6 microns at 50mg

STAG generated monodisperse 6 micron particles

DRUG

Placebo Comparator

No drug just solvent

DRUG

MDI FP

Trial Locations (2)

SW36LY

Asthma Lab, Royal Brompton Hospital, London

SW36NP

Department of Nuclear Medicine, Royal Brompton Hospital, London

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Imperial College London

OTHER